Eclampsia is defined as preeclampsia related new onset generalized tonic-clonic seizures and can result in significant morbidity and death. Postpartum eclampsia accounts for 10 to 44% of all cases of eclampsia. The differential diagnosis of postpartum seizures includes hypertensive encephalopathy, cerebrovascular accident, cerebral venous thrombosis, infection, metabolic abnormalities, and drug intoxication or withdrawal. Most patients with postpartum eclampsia present within a week of delivery. Early hospital discharge is the norm, so postpartum hypertensive disorders can go unrecognized, impairing the ability to prevent eclampsia.
Although the majority of women with postpartum eclampsia recall one or more prodromal symptoms, it is important to remain vigilant as not all women experience symptoms. Headache is the most common symptom, preceding seizure by hours to days. Discharge instructions may lack information about the signs, symptoms, and possibility of postpartum preeclampsia and eclampsia. As a result, only one third of patients with postpartum eclampsia seek medical care after discharge. When sought, it is often from primary or emergency department health care providers who may be not be adequately familiar with hypertensive disorders of pregnancy.
Eclampsia is diagnosed clinically based on generalized tonic-clonic seizures, which are sometimes accompanied by visual disturbances, headaches, epigastric or right upper quadrant pain, and altered mental status. Hyper-reflexia and non-dependent edema may be present. Laboratory abnormalities may include elevated liver transaminases, thrombocytopenia, proteinuria, hypoalbuminemia, and hyperuricemia. Laboratory values may be normal or only minimally abnormal. Overt proteinuria and severe range blood pressures are less prevalent in late onset postpartum eclampsia (2 to 6 weeks postpartum), which also may confound the diagnosis. Electroencephalogram has limited value in distinguishing seizures due to eclampsia from other causes. MRI can support the diagnosis and rule out other causes of new onset convulsions. The classic finding is symmetric, extensive vasogenic edema in the parieto-occipital region described as reversible posterior leukoencephalopathy. The posterior cerebral edema is best treated by normalizing blood pressures, diuresis, and administering magnesium sulfate. Treatment with magnesium sulfate should be immediately initiated upon diagnosis of eclampsia, and should be continued at least 24 to 48 hours after the last seizure.
Improved awareness and heightened surveillance are important measures to identify women with increased risk. Improved patient education with verbal counseling and written discharge information including danger signs and symptoms may impact the incidence of this condition. After delivery, patients may need an extended inpatient stay for further monitoring. Early follow up after discharge within 3-10 days is advised and based on the severity of the hypertension. Collaborative efforts to improve symptom recognition among primary care providers may promote early intervention.
American College of Obstetricians and Gynecologists. ACOG Practice Bulletin No. 202: Gestational Hypertension and Preeclampsia. Obstet Gynecol. 2019 Jan;133(1):e1-e25. doi: 10.1097/AOG.0000000000003018.
American College of Obstetricians and Gynecologists. ACOG Committee Opinion No. 736: Optimizing Postpartum Care. Obstet Gynecol. 2018 May;131(5):e140-e150. doi: 10.1097/AOG.0000000000002633.
Initial Approval November 2015; Revised July 2018; Reaffirmed January 2020; Revised September 2021. Minor Revision July 2023
********** Notice Regarding Use ************
The Society for Academic Specialists in General Obstetrics and Gynecology, Inc. (“SASGOG”) is committed to accuracy and will review and validate all Pearls on an ongoing basis to reflect current practice.
This document is designed to aid practitioners in providing appropriate obstetric and gynecologic care. Recommendations are derived from major society guidelines and high-quality evidence when available, supplemented by the opinion of the author and editorial board when necessary. It should not be construed as dictating an exclusive course of treatment or procedure to be followed.
Variations in practice may be warranted when, in the reasonable judgment of the treating clinician, such course of action is indicated by the condition of the patient, limitations of available resources, or advances in knowledge or technology. SASGOG reviews the articles regularly; however, its publications may not reflect the most recent evidence. While we make every effort to present accurate and reliable information, this publication is provided “as is” without any warranty of accuracy, reliability, or otherwise, either express or implied. SASGOG does not guarantee, warrant, or endorse the products or services of any firm, organization, or person. Neither SASGOG nor its respective officers, directors, members, employees, or agents will be liable for any loss, damage, or claim with respect to any liabilities, including direct, special, indirect, or consequential damages, incurred in connection with this publication or reliance on the information presented.
Copyright 2023 The Society for Academic Specialists in General Obstetrics and Gynecology, Inc. All rights reserved. No re-print, duplication or posting allowed without prior written consent.
Back to Search Results